BioSpace News Archive

CrossLink Life Sciences and Heron Therapeutics Partner to Boost ZYNRELEF® Promotion for Post-Operative Pain

Life Sciences, a leading medical device distributor and sales organization, is proud to announce a groundbreaking five-year partnership with Heron Therapeutics, Inc

January 11, 2024
·
1 min read
FDA

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia

GenFleet Therapeutics announced that U.S. Food and Drug Administration (FDA) has recently granted another two designations for SLS009 (GFH009).

January 11, 2024
·
4 min read
FDA

Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy

Neuralace Medical, Inc., an innovator in pain management technology, today proudly announces the FDA clearance of its groundbreaking product, Axon Therapy (mPNS), for the treatment of chronic Painful Diabetic Neuropathy (PDN).

January 11, 2024
·
3 min read
Business

Eleven Therapeutics Welcomes Dr. Paloma H Giangrande as Chief Technology Officer

Eleven Therapeutics proudly announces the appointment of Dr. Paloma H Giangrande as the company’s Chief Technology Officer (CTO).

January 11, 2024
·
3 min read
FDA

Zeta Surgical’s Mixed Reality Navigation System Receives FDA Special 510(k) Clearance for Expanded Functionality

Zeta Surgical announced today that its Zeta Cranial Navigation System has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded functionality through enhanced software features and compatibility with additional accessories.

January 11, 2024
·
1 min read
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Inc. is pleased to announce that it has received a notice of allowance from the Japanese Patent Office for patent application No. 2021-547495 entitled: Compositions and Methods for Treating Idiopathic Pulmonary Fibrosis (IPF).

January 11, 2024
·
4 min read
Business

SmartLabs Announces Biopharma Veteran Brian Taylor as New Interim CEO

SmartLabs, Inc. today announced that Brian Taylor has been appointed interim Chief Executive Officer effective January 5th.

January 11, 2024
·
2 min read
Business

Chemical Insights Research Institute Commits to Public Health Research with the Opening of New Laboratories

Chemical Insights Research Institute of UL Research Institutes confirmed its commitment to protecting environmental and human health when it opened its new research laboratories supporting scientific studies of environmental exposure and its societal health impact.

January 11, 2024
·
3 min read
Business

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Bone Biologics Corporation today announced that effective immediately Robert E. Gagnon has been named to the Company’s board of directors.

January 11, 2024
·
3 min read
Genetown

Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference

Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference.

January 11, 2024
·
1 min read